BioMérieux Q2 Revenues Grow 18 Percent | GenomeWeb

NEW YORK (GenomeWeb) – BioMérieux said today that its second quarter sales grew 18 percent, as the installed base of its FilmArray platform expanded to nearly 1,900 instruments.

For the three months ended June 30, the Marcy L'Etoile, France-based in vitro diagnostics firm reported revenues of €485.3 million ($526.6 million) compared to €409.9 million in Q2 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.